Company Overview of BioRexis Pharmaceuticals Corporation
As of March 31, 2007, BioRexis Pharmaceuticals Corporation was acquired by Pfizer Inc. BioRexis Pharmaceuticals Corporation develops and produces biopharmaceuticals. It offers protein and peptide drugs with pharmacology and Trans-bodies to replace conventional monoclonal antibodies. The company’s product includes peptide fusion, which is used for the treatment of type 2 diabetes. It also provides biopharmaceutical products for longer-acting interferon and an erythropoietin receptor agonist. The company was founded in 2002 and is based in King of Prussia, Pennsylvania.
3400 Horizon Drive
King of Prussia, PA 19406
Founded in 2002
Key Executives for BioRexis Pharmaceuticals Corporation
BioRexis Pharmaceuticals Corporation does not have any Key Executives recorded.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact BioRexis Pharmaceuticals Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.